Geron (GERN) EBITDA Margin (2016 - 2025)
Geron's EBITDA Margin history spans 16 years, with the latest figure at 19.35% for Q4 2025.
- For Q4 2025, EBITDA Margin rose 6197.0% year-over-year to 19.35%; the TTM value through Dec 2025 reached 1781.89%, down 155479.0%, while the annual FY2025 figure was 1781.89%, 155479.0% down from the prior year.
- EBITDA Margin for Q4 2025 was 19.35% at Geron, up from 29.4% in the prior quarter.
- Across five years, EBITDA Margin topped out at 25368.69% in Q4 2023 and bottomed at 190914.29% in Q1 2023.
- The 5-year median for EBITDA Margin is 15957.82% (2022), against an average of 29519.11%.
- The largest annual shift saw EBITDA Margin crashed -16760128bps in 2023 before it skyrocketed 17244915bps in 2024.
- A 5-year view of EBITDA Margin shows it stood at 2979.04% in 2021, then tumbled by -1267bps to 40729.13% in 2022, then surged by 162bps to 25368.69% in 2023, then tumbled by -100bps to 42.62% in 2024, then skyrocketed by 145bps to 19.35% in 2025.
- Per Business Quant, the three most recent readings for GERN's EBITDA Margin are 19.35% (Q4 2025), 29.4% (Q3 2025), and 25.4% (Q2 2025).